← Sharmila Dorbala

Papers by Sharmila Dorbala

Page 1 · newest first

1. Multicentre study of activity quantification methods for 99m-Tc-pyrophosphate SPECT/CT in cardiac amyloidosisPhysica Medica · 2026
2. Right Ventricular Bone-Avid Tracer Uptake: A Novel Risk Marker in Transthyretin Amyloid CardiomyopathyCirculation · 2024
3. Redefining Cardiac AmyloidosisJACC. Cardiovascular imaging · 2026
4. Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET RegistryCirculation Cardiovascular Imaging · 2026
5. Advanced Cardiovascular Imaging Findings and their Association with Outcomes in Patients with Suspected MyocarditisJournal of Nuclear Cardiology · 2026
6. Use of Myocardial Perfusion Imaging to Guide Prognosis and Management in Older Adults: Is There an Age Limit?Circulation Cardiovascular Imaging · 2026
7. 124 I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac AmyloidosisJAMA · 2026
8. The Role of Cardiac Fibrosis and Fibroblast Activation in Amyloid Light Chain (AL) AmyloidosisJACC Basic to Translational Science · 2026
9. Safety of Direct Current Cardioversion Without Routine Transesophageal Echocardiography in Patients With Cardiac AmyloidosisJournal of the American College of Cardiology · 2024
10. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathyEuropean Heart Journal · 2017
11. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese PatientsJournal of the American College of Cardiology · 2018
12. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19Journal of the American College of Cardiology · 2022
13. Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery DiseaseJournal of the American College of Cardiology · 2023
14. Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac SarcoidosisJournal of the American College of Cardiology · 2013
15. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected AmyloidosisJournal of the American College of Cardiology · 2020
16. AL (Light-Chain) Cardiac AmyloidosisJournal of the American College of Cardiology · 2016
17. Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseasesEuropean Heart Journal · 2023
18. International Impact of COVID-19 on the Diagnosis of Heart DiseaseJournal of the American College of Cardiology · 2021
19. Anatomic Versus Physiologic Assessment of Coronary Artery DiseaseJournal of the American College of Cardiology · 2013
20. Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imagingEuropean Heart Journal - Cardiovascular Imaging · 2025
21. Utility of ¹⁸ F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery DiseaseCirculation Cardiovascular Imaging · 2025
22. SNMMI/EANM/ASNC/ACNM Procedure Standard/Practice Guideline for ¹⁸F-Flurpiridaz PET Myocardial Perfusion Imaging and Blood Flow QuantitationJournal of Nuclear Medicine · 2025
23. Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosisBlood · 2025
24. Utility of 18F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive from Nonobstructive Coronary Artery Disease2025
25. AI-based identification of patients who benefit from revascularization: a multicenter study2025
26. FDA Approval of18F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?Journal of Nuclear Medicine · 2025
27. Echocardiographic Characterization of Myocardial Stiffness in Healthy Volunteers, Cardiac Amyloidosis, and Hypertrophic Cardiomyopathy: A Case-Control Study Using Multimodality ImagingCirculation Cardiovascular Imaging · 2025
28. Artificial Intelligence–Enhanced Perfusion Scoring Improves the Diagnostic Accuracy of Myocardial Perfusion ImagingJournal of Nuclear Medicine · 2025
29. Development of Imaging Endpoints for Clinical Trials in AL and ATTR AmyloidosisJACC. Cardiovascular imaging · 2025
30. Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomesEuropean Heart Journal · 2025
31. The Last Decade in Cardiac AmyloidosisJACC. Cardiovascular imaging · 2025
32. The Relationship Between Quantitative Ischemia, Early Revascularization, and Major Adverse Cardiovascular EventsJACC Advances · 2024
33. The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0)Journal of Nuclear Medicine · 2024
34. American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imagingJournal of Nuclear Cardiology · 2024
35. Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With HypertensionCirculation · 2024
36. Welcoming Discourse on the Approach for Gram-Negative Bacteremia and Candidemia in Cardiovascular Implantable Electronic Device InfectionsClinical Infectious Diseases · 2024
37. Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyFrontiers in Cardiovascular Medicine · 2024
38. Cardiovascular testing recovery in Latin America one year into the COVID-19 pandemic: An analysis of data from an international longitudinal surveyIJC Heart & Vasculature · 2024
39. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STSClinical Infectious Diseases · 2024
40. Impact of cardiac size on diagnostic performance of single-photon emission computed tomography myocardial perfusion imaging: insights from the REgistry of Fast Myocardial Perfusion Imaging with NExt generation single-photon emission computed tomographyEuropean Heart Journal - Cardiovascular Imaging · 2024
41. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisEuropean Heart Journal - Cardiovascular Imaging · 2024
42. Recovery of cardiovascular diagnostic testing in Italy 1 year after coronavirus disease-2019 outbreak compared with other countries in Europe and worldwide: results from the International Atomic Energy Agency INCAPS COVID 2 surveyEuropean Heart Journal - Imaging Methods and Practice · 2024
43. Clinical phenotypes among patients with normal cardiac perfusion using unsupervised learning: a retrospective observational studyEBioMedicine · 2024
44. Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney TransplantCirculation Cardiovascular Imaging · 2024
45. Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the FutureJournal of Nuclear Medicine · 2023
46. Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain Amyloidosis2023
47. Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide ComparisonRadiology Cardiothoracic Imaging · 2023
48. Prognostic Value of Left Ventricular ¹⁸ F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis2023
49. Feasibility of Simultaneous Quantification of Myocardial and Renal Perfusion With Cardiac Positron Emission TomographyCirculation Cardiovascular Imaging · 2023
50. Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2023